Join us and Entheogenic Researcher Larry Norris, PhD to explore why many natural substances remain criminalized despite their historical and cultural significance. We examine how decriminalization policies can better serve public health and social justice goals by reducing inequitable enforcement and shifting resources from punishment to risk reduction. Through a lens that questions the legitimacy of prohibiting access to nature, the talk makes a case for policy reform that respects both traditional relationships with plant medicines and modern evidence-based approaches.

Learn about the current federal and state Right to Try legislation and the federal Breakthrough Therapy Act legislation for investigational drugs and its application to expanding access to psychedelic therapies. I efforts that could enable patients faced with terminal illnesses to be prescribed investigational treatments to psychedelic medicines. Learn about how you can help move these efforts forward to help access experimental treatments and why these laws matter to the future of psychedelic care and access.‍

As the psychedelic community continues to explore alternative healing pathways, understanding how to safely transition off antidepressants is becoming increasingly important. Antidepressants can interact with certain psychedelics. However, many prescribers lack the knowledge or confidence to guide patients through a safe and effective tapering process. This webinar provides critical insights into managing antidepressant discontinuation, helping individuals and practitioners make informed decisions that may support safer, more effective healing experiences.